Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
出版年份 2018 全文链接
标题
Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy
作者
关键词
Metabolomics, Chemotherapy-induced peripheral neuropathy, Paclitaxel, Breast cancer, Nuclear magnetic resonance
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2018-06-27
DOI
10.1007/s10549-018-4862-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Abstract P6-11-03: Association of systemic paclitaxel concentrations with severity and progression of paclitaxel-induced peripheral neuropathy
- (2018) DL Hertz et al. CANCER RESEARCH
- Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
- (2018) Daniel L. Hertz et al. CLINICAL CANCER RESEARCH
- Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
- (2018) Lara E. Sucheston-Campbell et al. Pharmacogenetics and Genomics
- Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism
- (2017) Julie Trexel et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
- (2017) Gary R Zirpoli et al. JNCI-Journal of the National Cancer Institute
- Paclitaxel-induced painful neuropathy is associated with changes in mitochondrial bioenergetics, glycolysis, and an energy deficit in dorsal root ganglia neurons
- (2017) Natalie A. Duggett et al. PAIN
- Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials
- (2017) Jennifer Le-Rademacher et al. SUPPORTIVE CARE IN CANCER
- Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
- (2017) Gary R Zirpoli et al. JNCI-Journal of the National Cancer Institute
- Open-label, randomized study of individualized, pharmacokinetically (PK)-guided dosing of paclitaxel combined with carboplatin or cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
- (2016) M. Joerger et al. ANNALS OF ONCOLOGY
- Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy
- (2016) Hongmei Zhang et al. JOURNAL OF PAIN
- Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199
- (2015) B. P. Schneider et al. CLINICAL CANCER RESEARCH
- SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer
- (2015) George T. Budd et al. JOURNAL OF CLINICAL ONCOLOGY
- MetaboAnalyst 3.0—making metabolomics more meaningful
- (2015) Jianguo Xia et al. NUCLEIC ACIDS RESEARCH
- Effects of histidine andn-acetylcysteine on experimental lesions induced by doxorubicin in sciatic nerve of rats
- (2014) Amir Abbas Farshid et al. DRUG AND CHEMICAL TOXICOLOGY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemotherapy-Induced Peripheral Neurotoxicity and Ototoxicity: New Paradigms for Translational Genomics
- (2014) L. B. Travis et al. JNCI-Journal of the National Cancer Institute
- Signal Intensities Derived from Different NMR Probes and Parameters Contribute to Variations in Quantification of Metabolites
- (2014) Paige Lacy et al. PLoS One
- Pharmacometabolomics: Implications for Clinical Pharmacology and Systems Pharmacology
- (2013) R Kaddurah-Daouk et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy
- (2013) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- Effects of histamine on spontaneous neuropathic pain induced by peripheral axotomy
- (2013) Jie Yu et al. Neuroscience Bulletin
- Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
- (2013) Yaqin Han et al. Frontiers in Pharmacology
- Impact of Chemotherapy-Induced Peripheral Neuropathy on Treatment Delivery in Nonmetastatic Breast Cancer
- (2013) Rebecca M. Speck et al. Journal of Oncology Practice
- A Genome-Wide Association Study Identifies Novel Loci for Paclitaxel-Induced Sensory Peripheral Neuropathy in CALGB 40101
- (2012) R. M. Baldwin et al. CLINICAL CANCER RESEARCH
- Impact of oxaliplatin-induced neuropathy: a patient perspective
- (2012) Barbara K. Bennett et al. SUPPORTIVE CARE IN CANCER
- Alcoholic neuropathy: possible mechanisms and future treatment possibilities
- (2011) Kanwaljit Chopra et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacometabonomic Profiling as a Predictor of Toxicity in Patients with Inoperable Colorectal Cancer Treated with Capecitabine
- (2011) A. Backshall et al. CLINICAL CANCER RESEARCH
- Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat
- (2011) W.H. Xiao et al. NEUROSCIENCE
- Metscape: a Cytoscape plug-in for visualizing and interpreting metabolomic data in the context of human metabolic networks
- (2010) Jing Gao et al. BIOINFORMATICS
- Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach
- (2010) Hyuk Nam Kwon et al. KIDNEY INTERNATIONAL
- α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population
- (2010) Walter E. Gall et al. PLoS One
- From differentiating metabolites to biomarkers
- (2009) Albert Koulman et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Clinician versus nurse symptom reporting using the National Cancer Institute--Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire
- (2009) M. Cirillo et al. ANNALS OF ONCOLOGY
- Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
- (2009) H. C. Keun et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started